Isolated from ICU secondary infection in different samples of Acinetobacter baumannii resistance analysis
10.3969/j.issn.1673-4130.2015.14.043
- VernacularTitle:从ICU 继发感染者不同标本中分离鲍曼不动杆菌耐药性分析
- Author:
Guohui WEN
- Publication Type:Journal Article
- Keywords:
intensive care units;
different types of samples;
acinetobacter baumannii;
drug resistance
- From:
International Journal of Laboratory Medicine
2015;(14):2049-2050,2053
- CountryChina
- Language:Chinese
-
Abstract:
Objective Analysis isolated from ICU patients with severe types of different samples of Acinetobacter baumannii re‐sistance difference ,for effective prevention and control of Acinetobacter baumannii infection in ICU .Methods Retrospective analy‐sis of the college from January 2010 to December 2014 568 strains isolated from hospitalized ICU patients samples Acinetobacter baumannii clinical data .Results Isolated from ICU patients infected with Acinetobacter baumannii main source of sputum (60 .0% );drug sensitive test showed that Acinetobacter baumannii resistance to commonly used antimicrobial agents were generally multiple drug resistance ,the most sensitive to tigecycline ,cefoperazone/sulbactam ,resistance rate of less than 40 .0% ;isolated from sputum and sterile body fluid in Acinetobacter baumannii was generally higher than that of blood and urine to imipenem ,meropen‐em ,cefoperazone/sulbactam ,piperacillin/tazobactam ,ciprofloxacin ,levofloxacin ,amikacin resistance rate ,the difference was statis‐tically significant (P<0 .05) .Conclusion Acinetobacter baumannii multidrug resistant to commonly used antibiotics .In ICU differ‐ent specimen type drug resistance existence difference ,clinicians should strengthen the monitoring of drug resistance ,the treatment of the infection when the first choice of tigecycline ,Cefoperazone/sulbactam .
